Palmitic Acid-Free Omega-7 (Palmitoleic Acid) Provinal® purified omega 7 fatty acid sets the standard for purity — undergoing a unique process to remove saturated fatty acids and express high levels of palmitoleic acid (C16:1n7), which has been shown to help maintain normal C-reactive protein (CRP) levels. Other Omega 7 formulations on the market may contain upwards of 30% of palmitic acid, a saturated fatty acid that has been shown to have negative health effects.
Reducing insulin resistance and normalizing circulating insulin levels can prevent further weight gain and promote healthy weight loss efforts, goals and objectives. Additionally, improved insulin resistance results in disposing more sugar into the cells for utilization rather than storing it ectopically, (outside fat tissues) in the form of fat.*
Prediabetes means you have a higher than normal blood sugar level. It's not high enough to be considered type 2 diabetes yet. But without lifestyle changes, adults and children with prediabetes are at high risk to develop type 2 diabetes. Blood sugar values are expressed in milligrams of sugar per deciliter (mg/dL) or millimoles of sugar per liter (mmol/L) of blood. In general:
Interestingly, based upon extensive scientific research from many well-respected groups around the world, Omega-7 (palmitoleic acid or POA for short) actually has more extensive pharmacologic actions than the Omega-3′s. Virtually all of this research is published in leading scientific journals. Actions that have been reported to be attributed to Omega-7 include: improvements in lipid profiles, anti-inflammatory actions, improved insulin sensitivity & glucose metabolism, and even prevention of cholesterol and beta-amyloid deposition in both animal models and humans.
Safe and effective, we recommend a daily dosage is 420 mg/day (210 mg palmitoleic acid), in one small easy to swallow softgel.
Obesity is a vast and growing worldwide health problem that negatively affects many metabolic systems in the human body. Obesity increases the risk of diabetes, pancreatic function, insulin sensitivity and resistance, fatty liver disease, cardiovascular disease, cancer and the disruption of metabolic hormones which slow down metabolism that control fat deposition and weight accumulation. Consumers have spent over $600 billion dollars over the past 10 years on diet, obesity and weight loss products. New Gastric inhibitory hormone drugs have become popular but come at a steep price, typically $1,500 to $3,000 dollars, administered by injection with numerous side effects, some yet to be reported.
Unlike these drugs the Provinal® in Lippoa™ has no known side effects and naturally improves insulin resistance, systemic dyslipidemia, and liver and blood fat deposition and accumulation. Lippoa™ mimics the body’s own rescue mechanism to tackle obesity-related complications.*
"These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease;"
© Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details and accept the service to view the translations.